Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Stimatix GI is a medical device company specializing in innovative solutions for ostomy care, specifically focusing on improving the quality of life for patients with colostomies. The company developed the Artificial Ostomy Sphincter (AOS), a low-profile, non-bagging solution that allows patients to control their bowel movements and eliminate the need for traditional bulky ostomy bags. Founded in Israel as part of the Trendlines Group incubator, Stimatix GI's technology addresses the physical and psychological challenges associated with stoma management. In 2014, the company was acquired by B. Braun, a global leader in healthcare, to integrate its unique solutions into B. Braun's extensive ostomy product line. Their flagship products emphasize discretion, comfort, and patient autonomy, providing a significant advancement over conventional ostomy appliances.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Stimatix GI.